Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 116Neoplasms 97Prostatic Neoplasms 55Lung Neoplasms 47Colorectal Neoplasms 47Motor Activity 28Uterine Cervical Neoplasms 24Brain Neoplasms 24Pancreatic Neoplasms 20Ovarian Neoplasms 20Carcinoma, Hepatocellular 17Glioblastoma 16Head and Neck Neoplasms 15Rectal Neoplasms 14Depression 14Carcinoma, Non-Small-Cell Lung 14Stomach Neoplasms 13Leukemia 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 11Melanoma 11Glioma 11Disease 11Colonic Neoplasms 11Anxiety Disorders 11Papillomavirus Infections 10Hematologic Neoplasms 10Fatigue 9Endometrial Neoplasms 9Thyroid Neoplasms 8

Interventions

Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Thyroid Cancer, Papillary × 30 days × Clear all
NCT07529080 2026-06-09

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT07376837 2026-05-19

PTC-RFA

University Health Network, Toronto

Phase NA Recruiting
30 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡